Abiopharma

News list

MATA NATHAN L. 🟢 acquired 144.9K shares (1 derivative) of BELITE BIO, INC (BLTE) at $6.00 Transaction Date: Mar 31, 2026 | Filing ID: 140138

Full text

News bot April 2, 2026, 8:15 p.m.
🔍 MATA NATHAN L. (Executive)

Company: BELITE BIO, INC (BLTE)

Report Date: 2026-03-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 144,868
Detailed Transactions and Holdings:
- Acquired 144,868 shares of Stock Option (right to buy) at $6.0 per share (Derivative)
  Date: 2026-03-31 | Code: A | Expires: 2032-04-17 | Exercise: 2026-03-31 | equity_swap_involved: false | shares_owned_after: 267,934.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: On April 18, 2022, the reporting person was granted an option which shall vest in installments upon satisfaction of certain performance criteria. 123,066 ordinary shares subject to the option that had previously vested remain exercisable. One of the performance criteria was met on 3/31/2026, resulting in vesting of the option as to additional 144,868 ordinary shares.